Literature DB >> 22782822

Protocol for the rapid detection of the urogenital tract mollicutes and Chlamydia with concomitant LGV-(sub)typing.

Nadine Möbius1, Wibke Brenneisen, Anke Schaeffer, Birgit Henrich.   

Abstract

Urogenital tract infections can be caused by a number of pathogens, some of which, like the obligate intracellular Chlamydia trachomatis, are difficult to culture, or the cell wall-less mollicutes, like M. hominis or Ureaplasma spp. Real-time PCR (qPCR) has become an important diagnostic tool as it enables not only the species-specific detection of the organism but also the quantification essential to define the etiological relevance of a facultative pathogenic bacterium. We developed a set of TaqMan qPCRs for the detection of the species M. genitalium and M. hominis (Mh/Mg-duplex qPCR), U. parvum and U. urealyticum (Uu/Up duplex-PCR), and C. trachomatis (CT-qPCR), and for typing of lymphogranuloma venereum-associated L-serovars of C. trachomatis (LGV-qPCR) as well as a sub-typing of L1, L2, and L3. In addition, the human gap-gene was amplified as quality control of the specimen, and a cryptic plasmid co-amplified in CT-qPCR as an inhibition control. The present protocol focuses on the step-by-step description for the establishment of these TaqMan multiplex qPCRs.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22782822     DOI: 10.1007/978-1-61779-937-2_15

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  8 in total

1.  Ureaplasma-Driven Neonatal Neuroinflammation: Novel Insights from an Ovine Model.

Authors:  Christine Silwedel; Matthias C Hütten; Christian P Speer; Christoph Härtel; Axel Haarmann; Birgit Henrich; Maud P M Tijssen; Abdullah Ahmed Alnakhli; Owen B Spiller; Nicolas Schlegel; Silvia Seidenspinner; Boris W Kramer; Kirsten Glaser
Journal:  Cell Mol Neurobiol       Date:  2022-03-25       Impact factor: 5.046

2.  Ureaplasma Species Differentially Modulate Pro- and Anti-Inflammatory Cytokine Responses in Newborn and Adult Human Monocytes Pushing the State Toward Pro-Inflammation.

Authors:  Kirsten Glaser; Christine Silwedel; Markus Fehrholz; Ana M Waaga-Gasser; Birgit Henrich; Heike Claus; Christian P Speer
Journal:  Front Cell Infect Microbiol       Date:  2017-11-28       Impact factor: 5.293

3.  Validation of a novel Mho microarray for a comprehensive characterisation of the Mycoplasma hominis action in HeLa cell infection.

Authors:  Birgit Henrich; Freya Kretzmer; René Deenen; Karl Köhrer
Journal:  PLoS One       Date:  2017-07-28       Impact factor: 3.240

4.  Effect of Mycoplasma hominis and cytomegalovirus infection on pregnancy outcome: A prospective study of 200 Mongolian women and their newborns.

Authors:  Byambaa Otgonjargala; Kathrin Becker; Gunchin Batbaatar; Sandag Tsogtsaikhan; Jamsranjav Enkhtsetseg; Altangerel Enkhjargal; Klaus Pfeffer; Ortwin Adams; Chimeddorj Battogtokh; Birgit Henrich
Journal:  PLoS One       Date:  2017-03-03       Impact factor: 3.240

5.  Ureaplasma isolates stimulate pro-inflammatory CC chemokines and matrix metalloproteinase-9 in neonatal and adult monocytes.

Authors:  Kirsten Glaser; Christine Silwedel; Markus Fehrholz; Birgit Henrich; Ana Maria Waaga-Gasser; Heike Claus; Christian P Speer
Journal:  PLoS One       Date:  2018-03-20       Impact factor: 3.240

6.  Generation of Mycoplasma hominis gene-targeted mutants by targeting-induced local lesions in genomes (TILLING).

Authors:  S Pereyre; C Bénard; C Brès; C Le Roy; J P Mauxion; F Rideau; P Sirand-Pugnet; B Henrich; C Bébéar
Journal:  BMC Genomics       Date:  2018-07-09       Impact factor: 3.969

7.  Differential modulation of pulmonary caspases: Is this the key to Ureaplasma-driven chronic inflammation?

Authors:  Christine Silwedel; Markus Fehrholz; Christian P Speer; Katharina C Ruf; Steffi Manig; Kirsten Glaser
Journal:  PLoS One       Date:  2019-05-08       Impact factor: 3.240

8.  Host cell responses to persistent mycoplasmas--different stages in infection of HeLa cells with Mycoplasma hominis.

Authors:  Miriam Hopfe; René Deenen; Daniel Degrandi; Karl Köhrer; Birgit Henrich
Journal:  PLoS One       Date:  2013-01-11       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.